Rialto Wealth Management LLC Buys New Shares in Avantor, Inc. (NYSE:AVTR)

Rialto Wealth Management LLC acquired a new position in Avantor, Inc. (NYSE:AVTR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 84,426 shares of the company's stock, valued at approximately $1,779,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC grew its position in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after acquiring an additional 835 shares in the last quarter. US Bancorp DE boosted its stake in shares of Avantor by 6.2% in the third quarter. US Bancorp DE now owns 12,615 shares of the company's stock valued at $326,000 after buying an additional 734 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its position in Avantor by 45.3% during the third quarter. Robeco Institutional Asset Management B.V. now owns 86,225 shares of the company's stock worth $2,231,000 after buying an additional 26,884 shares during the period. Principal Financial Group Inc. grew its position in shares of Avantor by 146.5% in the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company's stock valued at $67,996,000 after purchasing an additional 1,562,018 shares during the last quarter. Finally, Portside Wealth Group LLC acquired a new stake in Avantor during the third quarter worth approximately $260,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Avantor

In other news, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now directly owns 40,604 shares of the company's stock, valued at $711,788.12. This represents a 10.78 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.

Remove Ads

Avantor Stock Down 6.6 %

Shares of Avantor stock traded down $1.13 during midday trading on Wednesday, reaching $15.81. 10,886,077 shares of the company's stock traded hands, compared to its average volume of 6,658,487. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a 52 week low of $15.37 and a 52 week high of $28.00. The company's 50 day simple moving average is $19.83 and its 200 day simple moving average is $22.21. The company has a market cap of $10.76 billion, a price-to-earnings ratio of 15.20, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the company earned $0.22 EPS. Equities analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on AVTR. Citigroup lowered their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. UBS Group restated a "neutral" rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Raymond James restated an "outperform" rating and set a $24.00 target price (down from $26.00) on shares of Avantor in a report on Monday, February 10th. Stifel Nicolaus reduced their price target on shares of Avantor from $28.00 to $26.00 and set a "buy" rating for the company in a research report on Monday, February 10th. Finally, Royal Bank of Canada reduced their price target on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Avantor presently has a consensus rating of "Moderate Buy" and an average price target of $25.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.